671 Phase 1 trial of human chimeric antigen receptor modified T cells (huCART-meso) administered in combination with oncolytic virus VCN-01 in patients with pancreatic and ovarian... by Carl H June, Joseph A Fraietta, Gabriela Plesa, Amy Marshall, Mark H O’Hara, Janos L Tanyi, Elizabeth Hexner, Julie Jadlowsky, Matthew Ferrara, Olivia Farrelly, Adam Runkle, Anne Chew, Emily Dowd, Vanessa Gonzalez, Neil C Sheppard